Mohamed Suliman

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023;38(Supplement_1):gfad063c_3437

#3437 THE ASSOCIATION OF INTERLEUKIN-6 TO ALBUMIN RATIO WITH MORTALITY IN PATIENTS WITH KIDNEY FAILURE

LI X; Qureshi ART; Suliman M; Heimbürger O; Barany FP; Stenvinkel P; Lindholm B
Article: FRONTIERS IN NUTRITION. 2023;10:1035343

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients.

Ryu K; Suliman ME; Qureshi AR; Chen Z; Avesani CM; Brismar TB; Ripsweden J; Barany P; Heimbürger O; Stenvinkel P; Lindholm B
Journal article: DUBAI DIABETES AND ENDOCRINOLOGY JOURNAL. 2023;29(2):67-88

Cardiometabolic Guidelines: Cardiovascular Risk Assessment and Management in Patients with Dysglycemia

Hassanein M; Sabbour H; Awadi FA; Abusnana S; Afandi B; Kaabi JA; Bashier A; Cosentino F; Tamimi HE; Farghali M; Farooqi MH; Hafidh K; Heshmat H; Hijazi R; Jabbar A; Kenz S; Nour SE; Shehab A; Shook J; Suliman M; Zaky H; Almahmeed W
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2023;54(7-8):268-274

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients.

Li X; Qureshi AR; Suliman ME; Heimburger O; Barany P; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(Supplement_3):gfac078.010

MO673: Association of Mean Corpuscular Volume with Mortality in Kidney Failure Patients: Opposite Findings in Chinese and Swedish Kidney Failure Patients

Lindholm B; Zhang X; Chen Z; Qureshi ART; Danielson K; Mukai H; Suliman M; Heimbürger O; Chen J; Stenvinkel P; Barany FP
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(Supplement_3):gfac078.045

MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts

Ryu K; Chen Z; Qureshi ART; Suliman M; Barany FP; Heimbürger O; Chen J; Stenvinkel P; Lindholm B
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(Supplement_3):gfac078.018

MO681: Association of Framingham Risk Score with Mortality in Kidney Failure Patients from China and Sweden

LI X; Chen Z; Rashid Tony Qureshi A; Mukai H; Suliman M; Heimbürger O; Peter Barany F; Chen J; Stenvinkel P; Lindholm B
Article: PEDIATRIC RESEARCH. 2022;91(3):539-544

Telomere length and telomere repeat-binding protein in children with sickle cell disease.

Suliman ME; Ansari MGA; Rayis MA; Hamza MA; Saeed AA; Mohammed AK; Al-Daghri NM
Article: ADVANCES IN PHYSIOLOGY EDUCATION. 2018;42(4):541-546

Recall of physiology knowledge among medical interns: an exploratory study in Riyadh, Saudi Arabia.

AlMohanna AM; Suliman ME; AlEssa NA; Khatib SY; Saeed AA; Hamza MA
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(2):274-282

Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.

Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2010;30(3):336-342

Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study.

Nascimento MM; Suliman ME; Silva M; Chinaglia T; Marchioro J; Hayashi SY; Riella MC; Lindholm B; Anderstam B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(3):901-906

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels.

Carrero JJ; Witasp A; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Suliman ME; Anderstam B; Lindholm B; Nordfors L; Schalling M; Axelsson J
Article: JORNAL BRASILEIRO DE NEFROLOGIA : ORG�O OFICIAL DE SOCIEDADES BRASILEIRA E LATINO-AMERICANA DE NEFROLOGIA. 2010;32(1):9-15

Association between body fat, inflammation and oxidative stress in hemodialysis.

Nihi MM; Manfro RC; Martins C; Suliman M; Murayama Y; Riella MC; Lindholm B; Nascimento MMD
Journal article: JORNAL BRASILEIRO DE NEFROLOGIA : ORG�O OFICIAL DE SOCIEDADES BRASILEIRA E LATINO-AMERICANA DE NEFROLOGIA. 2010;32(1):11-17

Associação entre gordura corporal, inflamação e estresse oxidativo na hemodiálise

Nihi MM; Manfro RC; Martins C; Suliman M; Murayama Y; Riella MC; Lindholm B; do Nascimento MM
Article: AMERICAN JOURNAL OF NEPHROLOGY. 2010;31(3):214-221

Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease.

Yilmaz MI; Qureshi AR; Carrero JJ; Saglam M; Suliman ME; Caglar K; Eyileten T; Sonmez A; Oguz Y; Vural A; Yenicesu M; Axelsson J
Article: JOURNAL OF NEPHROLOGY. 2009;22(6):774-782

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.

Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
Article: KIDNEY INTERNATIONAL. 2009;76(3):293-296

The kidney is the major site of S-adenosylhomocysteine disposal in humans.

Garibotto G; Valli A; Anderstam B; Eriksson M; Suliman ME; Balbi M; Rollando D; Vigo E; Lindholm B
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2008;38(11):804-811

Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.

Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
Article: CLINICA CHIMICA ACTA. 2008;395(1-2):106-110

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.

Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
Article: CLINICAL NUTRITION. 2008;27(4):557-564

Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.

Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Article: CLINICA CHIMICA ACTA. 2008;393(2):114-118

Modification of the oxidative stress biomarker AOPP assay: application in uremic samples.

Anderstam B; Ann-Christin B-H; Valli A; Stenvinkel P; Lindholm B; Suliman ME
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2008;3(4):976-985

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Suliman ME; Yilmaz MI; Carrero JJ; Qureshi AR; Saglam M; Ipcioglu OM; Yenicesu M; Tong M; Heimbürger O; Barany P; Alvestrand A; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2008;87(6):1860-1866

Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality.

Watanabe M; Suliman ME; Qureshi AR; Garcia-Lopez E; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Article: QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. 2008;101(5):397-405

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.

Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
Article: BLOOD PURIFICATION. 2008;26(2):204-210

Interleukin-6 is a better predictor of mortality as compared to C-reactive protein, homocysteine, pentosidine and advanced oxidation protein products in hemodialysis patients.

Pachaly MA; do Nascimento MM; Suliman ME; Hayashi SY; Riella MC; Manfro RC; Stenvinkel P; Lindholm B
Article: BLOOD PURIFICATION. 2008;26(6):555-560

Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.

Chmielewski M; Stenvinkel P; Luttropp K; Suliman ME; Qureshi AR; Carrero JJ; Barany P; Heimburger O; Nordfors L; Lindholm B
Article: BLOOD PURIFICATION. 2008;26(3):284-290

Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.

Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Article: JOURNAL OF INTERNAL MEDICINE. 2007;262(6):690-701

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.

Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
Article: SEMINARS IN DIALYSIS. 2007;20(6):523-529

Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.

Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;86(3):633-638

Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality.

Honda H; Qureshi AR; Axelsson J; Heimburger O; Suliman ME; Barany P; Stenvinkel P; Lindholm B
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2007;2(5):889-897

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.

Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(5):488-499

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?

Stenvinkel P; Karimi M; Johansson S; Axelsson J; Suliman M; Lindholm B; Heimbürger O; Barany P; Alvestrand A; Nordfors L; Qureshi AR; Ekström TJ; Schalling M
Article: CLINICA CHIMICA ACTA. 2007;379(1-2):87-94

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2007;85(3):695-701

Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite.

Carrero JJ; Qureshi AR; Axelsson J; Avesani CM; Suliman ME; Kato S; Bárány P; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2007;49(2):237-244

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(1):209-217

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Article: BLOOD PURIFICATION. 2007;25(2):210-218

Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients.

Grahl DA; Axelsson J; Nordfors L; Heimburger O; Bárány P; Gao Y-Z; Qureshi AR; Kato S; Watanabe M; Suliman M; Riella MC; Lindholm B; Stenvinkel P; Pecoits-Filho R
Article: CLINICAL NEPHROLOGY. 2006;66(6):418-425

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.

Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;48(5):761-771

J-shaped mortality relationship for uric acid in CKD.

Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Article: ANTIOXIDANTS & REDOX SIGNALING. 2006;8(11-12):2169-2173

Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?

Haghdoost S; Maruyama Y; Pecoits-Filho R; Heimburger O; Seeberger A; Anderstam B; Suliman ME; Czene S; Lindholm B; Stenvinkel P; Harms-Ringdahl M
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21(6):1603-1610

Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.

Suliman ME; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P
Article: JOURNAL OF RENAL NUTRITION. 2006;16(2):119-124

Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: a randomized placebo-controlled study.

Nascimento MM; Suliman ME; Murayama Y; Nihi M; Hayashi SY; Stenvinkel P; Riella MC; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2006;47(1):60-71

Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.

Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2005;82(2):342-349

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease.

Suliman ME; Qureshi AR; Stenvinkel P; Pecoits-Filho R; Bárány P; Heimbürger O; Anderstam B; Rodríguez Ayala E; Divino Filho JC; Alvestrand A; Lindholm B
Article: ATHEROSCLEROSIS. 2005;180(2):333-340

Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients.

Rodríguez-Ayala E; Anderstam B; Suliman ME; Seeberger A; Heimbürger O; Lindholm B; Stenvinkel P
Article: BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH. 2005;38(5):783-788

Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients.

Nascimento MM; Bruchfeld A; Suliman ME; Hayashi SY; Pecoits-Filho R; Manfro RC; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2004;19(12):3112-3116

The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.

Nascimento MM; Suliman ME; Bruchfeld A; Hayashi SY; Manfro RC; Qureshi AR; Pecoits-Filho R; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
Article: AMERICAN JOURNAL OF CLINICAL NUTRITION. 2004;80(5):1222-1229

Truncal fat mass as a contributor to inflammation in end-stage renal disease.

Axelsson J; Rashid Qureshi A; Suliman ME; Honda H; Pecoits-Filho R; Heimbürger O; Lindholm B; Cederholm T; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2004;44(3):455-465

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.

Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Journal article: HEMODIALYSIS INTERNATIONAL. 2004;8(1):102

The Influence of C‐Hepatitis on C‐Reactive Protein in a Cohort of Brazilian Hemodialysis Patients

Nascimento MM; Bruchfeld A; Suliman ME; Hayashi SY; Pecoits‐Filho R; Manfro RC; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(6):1212-1218

Associations between circulating inflammatory markers and residual renal function in CRF patients.

Pecoits-Filho R; Heimbürger O; Bárány P; Suliman M; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14(6):1614-1622

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.

Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2002;40(3):480-488

Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.

Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(6):1050-1056

Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.

Suliman ME; Bárány P; Divino Filho JC; Qureshi AR; Stenvinkel P; Heimbürger O; Anderstam B; Lindholm B; Bergström J
Article: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2001;39(8):734-738

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.

Suliman ME; Lindholm B; Bárány P; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2001;16(1):102-110

Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients.

Suliman ME; Filho JC; Bárány P; Anderstam B; Lindholm B; Bergström J
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1999;10(6):1287-1296

Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients.

Suliman ME; Divino Filho JC; Bàràny P; Anderstam B; Lindholm B; Bergström J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1997;12(11):2332-2338

Total, free, and protein-bound sulphur amino acids in uraemic patients.

Suliman ME; Anderstam B; Lindholm B; Bergström J
Article: KIDNEY INTERNATIONAL. 1996;50(5):1713-1717

Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.

Suliman ME; Anderstam B; Bergström J
Visa fler

Alla övriga publikationer

Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023;38:I516-I517

THE ASSOCIATION OF INTERLEUKIN-6 TO ALBUMIN RATIO WITH MORTALITY IN PATIENTS WITH KIDNEY FAILURE

Li X; Qureshi ART; Suliman M; Heimburger O; Barany FP; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I519

ASSOCIATION OF ATHEROGENIC INDEX OF PLASMA (AIP) WITH MORTALITY IN CHINESE AND SWEDISH END-STAGE KIDNEY DISEASE PATIENTS: RESULTS FROM TWO COHORTS

Ryu K; Chen Z; Qureshi ART; Suliman M; Barany FP; Heimburger O; Chen J; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I490-I492

ASSOCIATION OF MEAN CORPUSCULAR VOLUME WITH MORTALITY IN KIDNEY FAILURE PATIENTS: OPPOSITE FINDINGS IN CHINESE AND SWEDISH KIDNEY FAILURE PATIENTS

Lindholm B; Zhang X; Chen Z; Qureshi ART; Danielson K; Mukai H; Suliman M; Heimburger O; Chen J; Stenvinkel P; Barany FP
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I497-I498

ASSOCIATION OF FRAMINGHAM RISK SCORE WITH MORTALITY IN KIDNEY FAILURE PATIENTS FROM CHINA AND SWEDEN

Li X; Chen Z; Qureshi ART; Mukai H; Suliman M; Heimburger O; Barany FP; Chen J; Stenvinkel P; Lindholm B
Conference publication: FREE RADICAL BIOLOGY AND MEDICINE. 2009;47:S186

The Metabolism of Glutathione and its Related Dipeptides across Kidney, Splanchnic organs and Lung in Humans

Anderstam B; Suliman M; Valli A; Balbi M; Rollando D; Tosetti F; Lindholm B; Garibotto G
Conference publication: BLOOD PURIFICATION. 2009;28(4):318

Elevated Visfatin/NAMPT Correlates with Anorexia and Reduced Fasting Serum Amino Acids in CKD Patients

Jesus CJ; Witasp A; Lindholm B; Nordfors L; Schalling M; Axelsson J; Stenvinkel P; Qureshi AR; Heimburger O; Barany P; Suliman ME; Anderstam B
Editorial comment: SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION : AN OFFICIAL PUBLICATION OF THE SAUDI CENTER FOR ORGAN TRANSPLANTATION, SAUDI ARABIA.. 2008;19(3):329-345

Contribution of inflammation to vascular disease in chronic kidney disease patients.

Suliman ME; Stenvinkel P
Review: ADVANCES IN CLINICAL CHEMISTRY, VOL 99. 2008;46:217-262

Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.

Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22(7):2093

Homocysteine and reverse epidemiology - Reply

Suliman ME; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Lindholm B
Published conference paper: PERITONEAL DIALYSIS INTERNATIONAL. 2007;27 Suppl 2:S205-S209

Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.

García-López E; Carrero JJ; Suliman ME; Lindholm B; Stenvinkel P
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:141

S-adenosylhomocysteine levels are elevated and associated with cardiovascular disease in chronic kidney disease patients

Valli A; Carrero JJ; Suliman ME; Qureshi AR; Garibotto G; Barany P; Anderstam B; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007;22:140-141

Serum long pentraxin 3 (PTX3) levels predict death in chronic kidney disease (CKD) patients independently of CRP values

Tong M; Carrero JJ; Suliman M; Qureshi AR; Anderstam B; Axelsson J; Heimburger O; Barany P; Stenvinkel P; Alvestrand A; Lindholm B
Review: SEMINARS IN NEPHROLOGY. 2006;26(1):14-19

Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.

Suliman ME; Stenvinkel P; Bárány P; Rashid Qureshi A; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21:408

The osteoclast inhibitor osteoprotegerin is an independent predictor of survival in end-stage renal disease patients starting dialysis

Matsubara K; Anderstam B; Suliman M; Qureshi AR; Axelsson J; Martola L; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Editorial comment: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20(1):16-21

Homocysteine in uraemia--a puzzling and conflicting story.

Suliman ME; Bárány P; Kalantar-Zadeh K; Lindholm B; Stenvinkel P
Editorial comment: NEPHRON. 2005;101(4):c187-c189

Is hyperhomocysteinemia a contributor to atherosclerosis in chronic kidney disease patients?

Suliman ME; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V99

Bone mineral density is a predictor of survival in ESRD patients

Matsubara K; Suliman ME; Qureshi ART; Axelsson J; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V84

Factors associated with bone mineral density in CKD patients

Matsubara K; Suliman ME; Qureshi ART; Axelsson J; Anderstam B; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V83-V84

Plasma glutamate is related to the bone status in CKD patients

Suliman ME; Qureshi ART; Anderstam B; Matsubara K; Axelsson J; Divino JC; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005;20:V312

The ACE intron 16 del/del genotype is associated with mortality and inflammation in ESRD patients

Watanabe M; Nordfors L; Axelsson J; Barany P; Heimbürger O; Qureshi AR; Suliman M; Schalling M; Stenvinkel P; Lindholm B
Conference publication: NEPHROLOGY. 2005;10:A309

PLASMA SULFHYDRYLS AS A BIOMARKER OF OXIDATIVE STRESS IN CKD PATIENTS

Sjoberg BAK; Suliman M; Anderstam B; Alvestrand A
Published conference paper: KIDNEY INTERNATIONAL, SUPPLEMENT. 2003;(84):S172-S176

A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.

Pecoits-Filho R; Stenvinkel P; Marchlewska A; Heimburger O; Bárány P; Hoff CM; Holmes CJ; Suliman M; Lindholm B; Schalling M; Nordfors L
Published conference paper: AMERICAN JOURNAL OF KIDNEY DISEASES. 2003;41(3 Suppl 1):S89-S95

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.

Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:676A-677A

Change in common carotid intima media thickness (CC IMT), in first year of dialysis therapy, is related to plasma pentosidine content.

Suliman ME; Stenvinkel P; Jogestrand T; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:536A

Associations between circulating inflammatory markers and renal function in elderly subjects.

Pecoits R; Heimburger O; Stenvinkel P; Barany P; Suliman M; Lindholm B; Fehrman-Ekholm I
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:532A

Plasma total homocysteine (tHcy) is related to plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).

Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:195A

Higher plasma total homocysteine (tHcy) level is associated with better survival in patients (pts) with end-stage renal disease (ESRD)

Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:194A

Plasma total homocysteine (tHcy) is low in inflamed end-stage renal disease (ESRD) patients (pts)

Suliman ME; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:529A

Chronic inflammation independently reduces plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).

Suliman ME; Pecoits R; Stenvinkel P; Qureshi AR; Barany P; Heimburger O; Anderstam B; Ayala ER; Divino JC; Alvestrand A; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:530A

Relationship between circulating levels of interleukin-6 (IL-6) and fat mass in patients (pts) with end-stage renal disease (ESRD).

Suliman ME; Axelsson J; Heimburger O; Quershi AR; Barany P; Pecoits R; Lindholm B; Stenvinkel P
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:298A

Quantitative evaluation of systolic and diastolic function in chronic kidney disease (CKD) patients by color tissue velocity imaging (TVI)

Hayashi SY; Alvestrand A; Lindholm B; Rohani M; Brodin LA; Stenvinkel P; Lind B; Suliman MS; Lowbeer C; Seeberger A
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:825A

The influence of C Hepatitis on C-reactive protein (CRP) in a cohort of Brazilian hemodialysis patients.

Nascimento MM; Bruchfeld A; Suliman M; Stenvinkel P; Riella M; Manfro RC; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:705A

The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in hemodialysis patients.

Nascimento MM; Suliman ME; Riella MC; Stenvinkel P; Bruchfeld A; Pecoits R; Manfro R; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003;14:218A

Serum amino acids (sAA) levels and peritoneal permeability during local lipopolysaccharide (LPS) - Induced intraperitoneal inflammation.

Pawlaczyk K; Suliman ME; Kuzlan-Pawlaczyk M; Polubinska A; Czekalski S; Lindholm B; Breborowicz A
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2002;17(3):528-529

Accumulation of taurine in patients with renal failure.

Suliman ME; Bárány P; Filho JCD; Lindholm B; Bergström J
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:760A

Relationship between changes in plasma total homocysteine (tHcy) and serum albumin following renal replacement therapy (RRT).

Suliman ME; Stenvinkel P; Barany P; Heimburger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:466A-467A

No association between plasma total homocysteine (tHcy) and common carotid intima thickness (CC IMT) in end-stage renal disease (ESRD) patients (pts)

Suliman ME; Stenvinkel P; Barany P; Heimburger O; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:595A

Advanced oxidation protein products (AOPPs) in peritoneal dialysis (PD) effluent: Association to peritoneal solute transport rate (PSTR) and inflammation

Pecoits R; Suliman M; Heimburger O; Stenvinkel P; Anderstam B; Lindholm B
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002;13:594A

Plasma pentosidine is associated with inflammation but does not predict outcome in renal replacement therapy

Stenvinkel P; Suliman M; Olof H; Barany P; Pecoits R; Lindholm B
Published conference paper: KIDNEY INTERNATIONAL. 2000;57(4):1727-1735

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.

Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1997;8:A2903

Inhibition of nitric oxide (NO) attenuates ingestive behavior: Evidence for preference of ornithine pathway in uremia.

Mamoun AH; Sodersten P; Divino J; Suliman ME; Bergstrom J
Conference publication: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1996;7(9):A0398

Plasma total homocysteine is influenced by nutritional status in hemodialysis patients.

Suliman ME; Qureshi AR; Anderstam B; Gutierrez A; Lindholm B; Bergstrom J
Visa fler

Anställningar

Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2021-2024

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2001

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI